Keytruda® targets a protein on the surface of immune cells that stopped them from attacking the melanoma cells.Australis Photography/ShutterstockKeytruda® (pembrolizumab) is the latest drug to be registered in Australia for the treatment of widespread melanoma. This is the third class of drugs that improves survival in widespread melanoma...
More...
